Department of Clinical Oncology, Prince of Wales Hospital
Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong16 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma | Recurrent/ Metastatic NPC | Recruiting | Phase 2 | 2026-07-13 | NCT07690787 | |
| Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-06-18 | NCT06055465 | |
| CXD101 in Immunotherapy-related Liver Cancer | hepatocellular carcinoma | Active, not recruiting | Phase 2 | 2026-06-18 | NCT05873244 | |
| SBRT in HCC With Oligoprogression on First-line Immunotherapy | hepatocellular carcinoma | Recruiting | Not applicable | 2026-05-18 | NCT06434480 | |
| Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-04-01 | NCT07455955 | |
| Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2026-03-18 | NCT06295497 | |
| Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2026-03-04 | NCT06885879 | |
| SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis | hepatocellular carcinoma | Recruiting | Phase 2 | 2026-03-04 | NCT06823375 | |
| Cabozantinib in Hepatocellular Carcinoma | hepatocellular carcinoma | Active, not recruiting | Phase 2 | 2026-03-04 | NCT04588051 | |
| SRAM study_Postate Cancer | Advanced Prostate Cancer | Active, not recruiting | Phase 2 | 2026-03-04 | NCT03938649 | |
| Pembrolizumab in Hepatocellular Carcinoma | hepatocellular carcinoma | Active, not recruiting | Phase 2 | 2026-03-04 | NCT03419481 | |
| AKY15-HK-301_NEPA Study | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-03-04 | NCT03386617 | |
| Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-02-12 | NCT07379476 | |
| NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer | nasopharyngeal carcinoma | Active, not recruiting | Phase 2 | 2025-12-24 | NCT03734809 | |
| Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Not applicable | 2025-11-17 | NCT02339701 | |
| Fibroscan Study in HCC | Child's A to C Cirrhosis; Confirmed Diagnosis of Hepatocellular Carcinoma; Patients Who Are Scheduled to Undergo Transarterial Chemobolization, Systemic Therapy Surgery | Active, not recruiting | Not applicable | 2025-11-17 | NCT01796145 |